This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2013-2020.
Company Filing History:
Years Active: 2013-2020
Title: Innovations of Matthew John Edwards
Introduction
Matthew John Edwards is a notable inventor based in Horsham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of molecules that interact with thymic stromal lymphopoietin (TSLP). With a total of 3 patents to his name, Edwards continues to push the boundaries of scientific research and innovation.
Latest Patents
One of his latest patents focuses on TSLP-binding molecules and methods of using these molecules. This invention provides molecules, such as antibodies or antibody fragments, that specifically bind to TSLP. It also includes compositions comprising these molecules and methods for their production and use. This work is crucial for advancing therapeutic options in immunology.
Career Highlights
Matthew John Edwards is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Edwards has worked alongside notable colleagues, including Jean-Michel Rene Rondeau and Danforth Miller. These collaborations have further enriched his research and innovation efforts.
Conclusion
Matthew John Edwards exemplifies the spirit of innovation in biotechnology through his work on TSLP-binding molecules. His contributions are paving the way for new therapeutic approaches in the medical field.